These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 32446902)
1. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19. Tilocca B; Soggiu A; Sanguinetti M; Babini G; De Maio F; Britti D; Zecconi A; Bonizzi L; Urbani A; Roncada P Microbes Infect; 2020; 22(4-5):182-187. PubMed ID: 32446902 [TBL] [Abstract][Full Text] [Related]
2. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses. Tilocca B; Soggiu A; Sanguinetti M; Musella V; Britti D; Bonizzi L; Urbani A; Roncada P Microbes Infect; 2020; 22(4-5):188-194. PubMed ID: 32302675 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372 [TBL] [Abstract][Full Text] [Related]
4. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective. Uddin MB; Hasan M; Harun-Al-Rashid A; Ahsan MI; Imran MAS; Ahmed SSU Infect Genet Evol; 2020 Oct; 84():104440. PubMed ID: 32622082 [TBL] [Abstract][Full Text] [Related]
5. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome. Crooke SN; Ovsyannikova IG; Kennedy RB; Poland GA Sci Rep; 2020 Aug; 10(1):14179. PubMed ID: 32843695 [TBL] [Abstract][Full Text] [Related]
6. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics? Bianchi M; Benvenuto D; Giovanetti M; Angeletti S; Ciccozzi M; Pascarella S Biomed Res Int; 2020; 2020():4389089. PubMed ID: 32596311 [TBL] [Abstract][Full Text] [Related]
7. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2. Lon JR; Bai Y; Zhong B; Cai F; Du H Virol J; 2020 Oct; 17(1):165. PubMed ID: 33121513 [TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country. Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O Front Immunol; 2020; 11():2008. PubMed ID: 33013857 [TBL] [Abstract][Full Text] [Related]
9. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Grifoni A; Sidney J; Zhang Y; Scheuermann RH; Peters B; Sette A Cell Host Microbe; 2020 Apr; 27(4):671-680.e2. PubMed ID: 32183941 [TBL] [Abstract][Full Text] [Related]
10. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015 [TBL] [Abstract][Full Text] [Related]
11. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882 [TBL] [Abstract][Full Text] [Related]
12. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine. Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515 [TBL] [Abstract][Full Text] [Related]
13. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development. Banerjee A; Santra D; Maiti S J Transl Med; 2020 Jul; 18(1):281. PubMed ID: 32650788 [TBL] [Abstract][Full Text] [Related]
14. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes. Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237 [TBL] [Abstract][Full Text] [Related]
15. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381 [TBL] [Abstract][Full Text] [Related]
17. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Xiao K; Zhai J; Feng Y; Zhou N; Zhang X; Zou JJ; Li N; Guo Y; Li X; Shen X; Zhang Z; Shu F; Huang W; Li Y; Zhang Z; Chen RA; Wu YJ; Peng SM; Huang M; Xie WJ; Cai QH; Hou FH; Chen W; Xiao L; Shen Y Nature; 2020 Jul; 583(7815):286-289. PubMed ID: 32380510 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis of COVID-19 relationships in different species: a one health perspective. Tilocca B; Soggiu A; Musella V; Britti D; Sanguinetti M; Urbani A; Roncada P Microbes Infect; 2020; 22(4-5):218-220. PubMed ID: 32194253 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 envelope protein topology in eukaryotic membranes. Duart G; García-Murria MJ; Grau B; Acosta-Cáceres JM; Martínez-Gil L; Mingarro I Open Biol; 2020 Sep; 10(9):200209. PubMed ID: 32898469 [TBL] [Abstract][Full Text] [Related]
20. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies. Sarkar M; Saha S PLoS One; 2020; 15(8):e0237300. PubMed ID: 32785274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]